Sail over hurdles and challenges posed in monoclonal antibody development with Covance. The versatility of monoclonal antibodies as therapeutics, diagnostics and reagents in drug discovery research poses numerous opportunities and challenges for their developers. Complex issues include:
- Product characterization
- Extensive testing of raw materials and cell banks for adventitious agents
- Viral clearance process validation
Use Covance Biopharmaceutical Services for all your monoclonal antibody development needs. If a monoclonal antibody is produced through recombinant DNA technologies, all tests required for recombinant proteins need to be considered. Whether your desire is for hybridoma characterization, tissue cross-reactivity, or to assess the specificity, potency, and isotype of the monoclonal antibodies your hybridoma secretes, the protein analytical and immunochemistry services of Covance is here to help you succeed.